<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="121188">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02122471</url>
  </required_header>
  <id_info>
    <org_study_id>SP304203-03</org_study_id>
    <nct_id>NCT02122471</nct_id>
  </id_info>
  <brief_title>12-Week Study of Plecanatide for CIC (The National CIC3 Study)</brief_title>
  <acronym>CIC</acronym>
  <official_title>A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Synergy Pharmaceuticals Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Synergy Pharmaceuticals Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to confirm that the investigational medication, plecanatide, is
      safe and effective in treating chronic idiopathic constipation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a national, randomized, 12-week, double-blind, placebo-controlled, study in
      approximately 1350 adult male and female patients with CIC comparing 2 doses of plecanatide
      to placebo. The study will be conducted at approximately 180 clinical study sites in the
      United States. The primary objective of the study is to evaluate the efficacy and safety of
      3.0 and 6.0 mg of plecanatide administered once daily (QD) for 12 weeks in a population of
      patients with CIC. The study population will include only patients without other causes of
      constipation or other chronic conditions that could interfere with study assessments.
      Patients may not take laxatives (with the exception of the study-provided rescue medication,
      bisacodyl 5mg tablets), or a number of prohibited drugs that are known to cause constipation
      or diarrhea, during study participation.

      There are 6 scheduled study visits, including the screening and follow-up visits. The
      planned duration of participation in this study will be 112 days and up to 155 days, with
      washout and all visit windows considered.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Proportion of patients who are overall responders</measure>
    <time_frame>12-week Treatment Period</time_frame>
    <safety_issue>No</safety_issue>
    <description>The study's primary efficacy endpoint is the proportion of patients who are overall responders for the 12-week Treatment Period.
An overall responder is defined as a weekly responder for at least 9 of the 12 treatment weeks, including at least 3 of the last 4 weeks. A weekly responder is defined as a patient who has ≥ 3 Complete Spontaneous Bowel Movements (CSBMs) per week and an increase from baseline of ≥1 CSBM for that week. A CSBM is a bowel movement that occurs in the absence of laxative use within 24 hours and is associated with the feeling of complete evacuation.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1350</enrollment>
  <condition>Chronic Idiopathic Constipation</condition>
  <arm_group>
    <arm_group_label>Plecanatide 3.0 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Plecanatide tablets 3.0 mg QD for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plecanatide 6.0 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Plecanatide tablets 6.0 mg QD for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo tablets QD for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Plecanatide</intervention_name>
    <arm_group_label>Plecanatide 3.0 mg</arm_group_label>
    <arm_group_label>Plecanatide 6.0 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female aged 18-80, inclusive

          -  Meets modified Rome III criteria for functional chronic  idiopathic
             constipation for at least 3 months with symptom onset for at least 6 months

          -  Completed a colonoscopy in accordance with American Gastroenterological Association
             (AGA) colon cancer screening guidelines (5 years), with no clinically significant
             findings

          -  Willing to maintain a stable diet during the study

        Exclusion Criteria:

          -  Loose stool (mushy) or watery (Bristol score 6 or 7) stool in the absence of any
             laxative or prohibited medicine for &gt; 25% of Bowel Movements (BMs) during the 3
             months prior to screening visit OR during the 14 day pre-treatment assessment

          -  Active peptic ulcer disease, diabetes or hypertension not adequately treated or not
             stable

          -  History of cathartic colon, laxative, enema abuse, or ischemic colitis

          -  Fecal impaction within 3 months of screening

          -  Patient has had /has any: diseases or conditions associated with constipation (GI or
             CNS), structural abnormality of the GI tract or gastric bypass surgery, pelvic floor
             dysfunction, pseudo-obstruction, active infectious gastritis, diverticulitis, anal
             fissures or any disease or condition that can affect GI motility or defecation or can
             be associated with abdominal pain

          -  Unexplained and clinically significant &quot;alarm symptoms&quot; including lower GI bleeding,
             iron-deficiency anemia, weight loss or systemic signs of infection or colitis

          -  Major surgery, stroke or myocardial infarction (MI) within 60 days of screening

          -  Participated in a previous plecanatide clinical trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary Beth Layton</last_name>
    <role>Study Director</role>
    <affiliation>Synergy Pharmaceuticals Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Genova Clinical Research, Inc.</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leah M Schmidt, DO</last_name>
      <phone>520-219-6394</phone>
      <email>lschmidt@genovaresearch.com</email>
    </contact>
    <investigator>
      <last_name>Leah M Schmidt, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Research Enterprises, Inc</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85715</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>German Lasala, MD</last_name>
      <phone>520-333-0765</phone>
      <email>spalm@are-inc.com</email>
    </contact>
    <investigator>
      <last_name>German Lasala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Rx Clinical Research</name>
      <address>
        <city>Artesia</city>
        <state>California</state>
        <zip>90701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dinh V Dinh, DO</last_name>
      <phone>562-860-8171</phone>
      <email>dinh@advancedrxclinicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Dinh V Dinh, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Rx Clinical Research- Garden Grove</name>
      <address>
        <city>Garden Grove</city>
        <state>California</state>
        <zip>92843</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phu Thien Nguyen, DO</last_name>
      <phone>714-554-8080</phone>
      <email>drphunguyenarcr@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Phu Thien Nguyen, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alliance Research Centers</name>
      <address>
        <city>Laguna Hills</city>
        <state>California</state>
        <zip>92653</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenneth B Deck, MD</last_name>
      <phone>949-680-3490</phone>
      <email>kdeck@researchalliance.com</email>
    </contact>
    <investigator>
      <last_name>Kenneth B Deck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SDS Clinical Trials, Inc.</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew O Schreiber, MD</last_name>
      <phone>714-834-1565</phone>
      <email>Drschreiber@sdsclinicaltrials.com</email>
    </contact>
    <investigator>
      <last_name>Andrew O Schreiber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northern California Research</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95821</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas G Young, MD</last_name>
      <phone>916-484-0500</phone>
      <email>3840.MD@norcare.net</email>
    </contact>
    <investigator>
      <last_name>Douglas G Young, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Artemis Institute for Clinical Research</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Layle, MD</last_name>
      <phone>858-278-3647</phone>
      <email>SLAYLE@ARTEMIS-RESEARCH.COM</email>
    </contact>
    <investigator>
      <last_name>Stacey Layle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pinon Family Practice</name>
      <address>
        <city>Littleton</city>
        <state>Colorado</state>
        <zip>80128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darcy E Scheeler, MD</last_name>
      <phone>303-948-2676</phone>
      <email>darcyscheeler@me.com</email>
    </contact>
    <investigator>
      <last_name>Darcy E Scheeler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Innovative Research of West Fl., Inc.</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel E Trevino, MD</last_name>
      <phone>727-584-8777</phone>
      <email>miguelt@innovativeresearchfl.com</email>
    </contact>
    <investigator>
      <last_name>Miguel E Trevino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Avail Clinical Research, LLC</name>
      <address>
        <city>DeLand,</city>
        <state>Florida</state>
        <zip>32720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie VanDermark, MD</last_name>
      <phone>386-785-2400</phone>
      <email>mvandemark@availclinical.com</email>
    </contact>
    <investigator>
      <last_name>Melanie VanDermark, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Health Center</name>
      <address>
        <city>Ft. Lauderdale</city>
        <state>Florida</state>
        <zip>33312</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bart K Gershenbaum, DO</last_name>
      <phone>954-584-7449</phone>
      <email>DrGFloridaHC@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Bart K Gershenbaum, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eastern Research, Inc.</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Sanchez, MD</last_name>
      <phone>305-681-3111</phone>
      <email>eastrehab@aol.com</email>
    </contact>
    <investigator>
      <last_name>Manuel Sanchez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Homestead Medical Research</name>
      <address>
        <city>Homestead</city>
        <state>Florida</state>
        <zip>33030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael D Feldman, DO</last_name>
      <phone>305-338-0568</phone>
      <email>mike@aktamedika.com</email>
    </contact>
    <investigator>
      <last_name>Michael D Feldman, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Care Partners Clinical Research</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32277</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Barbel-Johnson, DO MPA</last_name>
      <phone>904-296-3260</phone>
      <email>kbjohnson@familycarepartners.com</email>
    </contact>
    <investigator>
      <last_name>Kim Barbel-Johnson, DO, MPA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Neuroscience Solutions, Inc.</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fadi  Raji Chalhoub, MD</last_name>
      <phone>904-281-5757</phone>
      <email>fchalhoub@cnshealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Fadi  Raji Chalhoub, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nuren Medical &amp; Research Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hector M Maldonaldo, MD</last_name>
      <phone>305-551-8493</phone>
      <email>maldonado@nurenmedical.com</email>
    </contact>
    <investigator>
      <last_name>Hector M Maldonaldo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SouthCoast Research Center, Inc</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alvaro Javier Ocampo, MD, MPH</last_name>
      <phone>786-343-6937</phone>
      <email>pi1@southresearch.org</email>
    </contact>
    <investigator>
      <last_name>Alvaro Javier Ocampo, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LCC Medical Research Institute, LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33126</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yamirka Duardo Guerra, MD</last_name>
      <phone>305-400-0814</phone>
      <email>drduardo@lccmedicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Yamirka Duardo Guerra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Research Institute of South Florida, Inc.</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Sotolongo, MD</last_name>
      <phone>608-541-8226</phone>
      <email>rsotolongo@miamimedtrials.com</email>
    </contact>
    <investigator>
      <last_name>Roberto Sotolongo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Medical Center &amp; Research</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33142</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramon Berenguer, MD</last_name>
      <phone>786-378-8200</phone>
      <email>rberenguer@flmedresearch.com</email>
    </contact>
    <investigator>
      <last_name>Ramon Berenguer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Future Clinical Research, Corp.</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raul A Tamayo, MD</last_name>
      <phone>305-477-6750</phone>
      <email>rtamayo@futureclinicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Raul A Tamayo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Global Health Research Center</name>
      <address>
        <city>Miami Lakes</city>
        <state>Florida</state>
        <zip>33016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blanca Gonzalez, MD</last_name>
      <phone>305-824-0026</phone>
      <email>bgonzalez@globalheaithcenter.com</email>
    </contact>
    <investigator>
      <last_name>Blanca Gonzalez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harmony Clinical Research, Inc.</name>
      <address>
        <city>North Miami Beach</city>
        <state>Florida</state>
        <zip>33162</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adonis Maiquez, MD</last_name>
      <phone>305-957-7200</phone>
      <email>amaiquez@hcresearchfl.com</email>
    </contact>
    <investigator>
      <last_name>Adonis Maiquez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Neuroscience Solutions, Inc.</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Edward Dever, MD</last_name>
      <phone>407-425-5100</phone>
      <email>mdever@cnshealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Michael Edward Dever, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pines Care Research Center, LLC</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33026</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Prida, MD</last_name>
      <phone>954-251-1497</phone>
      <email>k_prida@aol.com</email>
    </contact>
    <investigator>
      <last_name>Karen Prida, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Physician Care Clinical Research</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>G. Michael Swor, MD</last_name>
      <phone>941-954-2355</phone>
      <email>GMSWOR@comcast.net</email>
    </contact>
    <investigator>
      <last_name>G. Michael Swor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Trials of Florida, Inc.</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sady Aplizar, MD</last_name>
      <phone>813-873-8102</phone>
      <email>s.alpizar.md@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sady Aplizar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Agile Clinical Research Trials,LLC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vasundhara Cheekati, MD</last_name>
      <phone>678-799-9136</phone>
      <email>drvasu@agilecrt.com</email>
    </contact>
    <investigator>
      <last_name>Vasundhara Cheekati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgia Clinical Research, LLC</name>
      <address>
        <city>Snellville</city>
        <state>Georgia</state>
        <zip>30078</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John David Lentz, III, MD</last_name>
      <phone>678-822-5581</phone>
      <email>Georgiaclinicalresearch@comcast.net</email>
    </contact>
    <investigator>
      <last_name>John David Lentz, III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Independent Clinical Researcherts @ Wolfson Medical Center</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Wolfson, DO</last_name>
      <phone>702-869-1786</phone>
      <email>Icrinvestigator1@aol.com</email>
    </contact>
    <investigator>
      <last_name>Eric Wolfson, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Jersey Medical Associates, PA</name>
      <address>
        <city>Blackwood</city>
        <state>New Jersey</state>
        <zip>08012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald G Intelisano, DO</last_name>
      <phone>856-228-0144</phone>
      <email>sjma71@comcast.net</email>
    </contact>
    <investigator>
      <last_name>Ronald G Intelisano, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Manhattan Medical Research Practice, PLLC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ian Lustbader, MD</last_name>
      <phone>212-480-3333</phone>
      <email>ilustbader@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ian Lustbader, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PMG Research of Charlotte</name>
      <address>
        <city>Concord</city>
        <state>North Carolina</state>
        <zip>28025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fred C Fowler, MD</last_name>
      <phone>704-527-6672</phone>
      <email>fflowler@pmg-research.net</email>
    </contact>
    <investigator>
      <last_name>Fred C Fowler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PMG Research of Hickory, LLC</name>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <zip>28602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Keith Earl, MD</last_name>
      <phone>828-345-5060</phone>
      <email>jearl@pmg-research.com</email>
    </contact>
    <investigator>
      <last_name>John Keith Earl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peters Medical Research</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Jarrett, MD</last_name>
      <phone>336-883-9773</phone>
      <email>thomasj@petersmedicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Jarrett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PMG Research of Raleigh</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Rubino, MD</last_name>
      <phone>919-783-4895</phone>
      <email>jrubino@pmg-research.com</email>
    </contact>
    <investigator>
      <last_name>John Rubino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hightop Medical Research Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James I Fidelholtz, MD</last_name>
      <phone>513-681-0606</phone>
      <email>jamesfidelholtz@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>James I Fidelholtz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Family Practice Center of Wadsworth, Inc.</name>
      <address>
        <city>Wadsworth</city>
        <state>Ohio</state>
        <zip>44203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew P Finneran, MD, FAAFP</last_name>
      <phone>330-334-6229</phone>
      <email>mfinneran@fpcwadsworth.com</email>
    </contact>
    <investigator>
      <last_name>Matthew P Finneran, MD, FAAFP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PMG Research of Bristol, LLC</name>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <zip>37620</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Powell, MD</last_name>
      <phone>423-989-3105</phone>
      <email>spowell@pmg-research.com</email>
    </contact>
    <investigator>
      <last_name>Stephanie Powell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastroenterology Associates</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas Homoky, MD</last_name>
      <phone>423-230-3154</phone>
      <email>douglas_homoky@gastrotn.com</email>
    </contact>
    <investigator>
      <last_name>Douglas Homoky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PMG Research of Knoxville</name>
      <address>
        <city>Knoxville,</city>
        <state>Tennessee</state>
        <zip>37938</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rickey D Manning, MD</last_name>
      <phone>865-244-4276</phone>
      <email>rmanning@pmg-research.com</email>
    </contact>
    <investigator>
      <last_name>Rickey D Manning, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FutureSearch Trials of Dallas, LP</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael James Downing, MD</last_name>
      <phone>916-934-0569</phone>
      <email>michaeld@fstrials.com</email>
    </contact>
    <investigator>
      <last_name>Michael James Downing, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>May 27, 2014</lastchanged_date>
  <firstreceived_date>April 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CIC</keyword>
  <keyword>Constipation</keyword>
  <keyword>Chronic Constipation</keyword>
  <keyword>Synergy</keyword>
  <keyword>Plecanatide</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
